Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/STX stock hub

AIM/STX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/STXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

73.3M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/STX

In the news

Latest news · AIM/STX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-31.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/STX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	63
Employees Change	-10%
Employees Change Percent	-13.7
Enterprise value	GBX 87M
Exchange	London Stock Exchange AIM
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	GB00BYV81293
Last refreshed	2026-05-10
Market cap	GBX 73.3M
Price	GBX 6.86
Price currency	GBX
Rev Per Employee	586,156.24x
Sector	Healthcare
Sic	2834
Symbol	aim/STX
Website	https://www.shieldtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.9%
EV Earnings	-6.64x
EV/FCF	-34.42x
EV/Sales	2.36x
FCF yield	-3.45%
P/B ratio	-6.54x
P/S ratio	1.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-20.22%
EBITDA Margin	-17.98%
Gross margin	46.36%
Gross Profit	GBX 17.1M
Gross Profit Growth	14.85%
Gross Profit Growth Q	31.45%
Gross Profit Growth3 Y	43.32%
Gross Profit Growth5 Y	54.22%
Net Income	GBX -13.1M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	-34.49%
Profit Margin	-35.52%
Profit Per Employee	GBX -208,217
ROA	-10.24
Roa5y	-34.28
ROCE	-66.74
ROIC	-31.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.36%
Cagr1y	169.2%
Cagr3y	-2.93%
Cagr5y	-31.84%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	54.45x
Revenue Growth Q	40.93x
Revenue Growth Quarters	8x
Revenue Growth Years	4x
Revenue Growth3 Y	32.28x
Revenue Growth5 Y	49.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.81
Assets	GBX 48.5M
Cash	GBX 8.6M
Current Assets	GBX 33.2M
Current Liabilities	GBX 36.8M
Debt	GBX 22.4M
Debt FCF	GBX -8.85
Equity	GBX -11.2M
Interest Coverage	-1.35
Liabilities	GBX 59.7M
Long Term Assets	GBX 15.3M
Long Term Liabilities	GBX 22.9M
Net Cash	GBX -13.8M
Net Cash By Market Cap	GBX -18.77
Tangible Book Value	GBX -25.2M
Tangible Book Value Per Share	GBX -0.03
WACC	15.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.9
Inventory Turnover	3.58
Net Working Capital	GBX -12.3M
Quick ratio	0.72
Working Capital	GBX -3.7M
Working Capital Turnover	GBX 197

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.91%
1Y total return	169.02%
200-day SMA	8.47
3Y total return	-8.53%
50-day SMA	8.61
50-day SMA vs 200-day SMA	50over200
5Y total return	-85.29%
All Time High	202
All Time High Change	-96.6%
All Time High Date	2019-07-30
All Time Low	1.06
All Time Low Change	545.34%
All Time Low Date	2024-04-25
ATR	0.59
Beta	1.88
Beta1y	3.33
Beta2y	2.06
Ch YTD	-30.36
High	6.9
High52	12.5
High52 Date	2026-01-16
High52ch	-45.12%
Low	6.5
Low52	2.2
Low52 Date	2025-05-16
Low52ch	211.82%
Ma50ch	-20.36%
Price vs 200-day SMA	-19.02%
RSI	26.32
RSI Monthly	47.17
RSI Weekly	41.59
Sharpe ratio	1.62x
Sortino ratio	3.31
Total Return	-12.77%
Tr YTD	-30.36
Tr1m	-17.84%
Tr1w	-13.16%
Tr3m	-28.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -7.5M
Operating margin	-20.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	411,580,968%
Net Borrowing	1,109,073.2
Shares Insiders	1.7%
Shares Institutions	32.52%
Shares Out	1,068,418,471
Shares Qo Q	-30.52%
Shares Yo Y	12.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -3.1M
Average Volume	3,128,497.3x
Bv Per Share	-0.02
CAPEX	GBX -17,832
Ch10y	-96.14
Ch1m	-17.84
Ch1w	-13.16
Ch1y	169
Ch3m	-28.54
Ch3y	-8.53
Ch5y	-85.71
Ch6m	0.15
Change	1.63%
Change From Open	1.63
Close	6.75
Days Gap	0
Depreciation Amortization	817,868.1
Dollar Volume	15,847,368.3
Earnings Date	2026-06-04
EBIT	GBX -7.5M
EBITDA	GBX -6.6M
EPS	GBX -0.01
F Score	3
FCF	GBX -2.5M
FCF EV Yield	-2.91x
FCF Per Share	GBX -0
Financing CF	6,410,604
Fiscal Year End	December
Founded	2,008
Income Tax	GBX 381,902
Investing CF	-155,287
Is Primary Listing	1
Last Earnings Date	2025-09-05
Last Report Date	2025-12-31
Ma150	9.09
Ma150ch	-24.55%
Ma20	8.64
Ma20ch	-20.57%
Net CF	3,787,071
Next Earnings Date	2026-06-04
Open	6.75
Position In Range	90
Ppne	82,887.1
Price Date	2026-05-08
Relative Volume	0.76x
Revenue	36,927,843x
SBC By Revenue	1.59x
Share Based Comp	587,713
Tax By Revenue	1.03x
Tr6m	0.15%
Volume	2,310,112
Z Score	-5.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/STX pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/STX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/STX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.5%

Share of float held by funds and institutions

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.8%

Negative means the company is buying back shares.

Technical

AIM/STX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.3

Below 30: short-term oversold

Price vs 200-day MA

-19.0%

50/200-day relationship not available

Beta (5Y)

1.88

More volatile than the market

Sharpe ratio

1.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/STX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/STX stock rating?

aim/STX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/STX analysis?

The full report lives at /stocks/aim/STX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/STX?

The latest report frames aim/STX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/STX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.